A new poll shows an overhwhelming majority of Marylanders believe drug makers could reduce costs for prescription drugs ...

Araris will use its linker technology to generate multi-warhead ADCs for “undisclosed targets” provided by Chugai.

The industry is set to make notable progress in cutting-edge areas such as CAR-T cell therapy, mRNA vaccines, and the ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

The pharma and life sciences industry faces a dynamic year ahead, driven by AI, sustainability, and evolving regulations. Stricter ESG reporting and economic uncertainty create new challenges. Success ...

The pharmaceutical industry argues that lower prices will have catastrophic effects on research and development, while other suggest that curbing drug prices will result in only modest cuts in the ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

TAS-0728 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Biliary Tumor. According to GlobalData, Phase II drugs for Biliary Tumor does not have sufficient ...

ReactWise Introduces AI-Powered Technology to Transform the Global Pharmaceutical Industry.London, United Kingdom, January 8, ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitementand skepticism ...